KYONGBO
LIVE

Serial Number

79437200

Owner

KYONGBO PHARM.CO.,LTD.

Attorney

Miriam D. Trudell

Filing Date

Sep 3, 2025

Add to watchlist:

No watchlists yet
View on USPTO

KYONGBO Trademark

Serial Number: 79437200

KYONGBO is a trademark filed by KYONGBO PHARM.CO.,LTD. on September 3, 2025. The trademark is classified under Class 5 (Pharmaceuticals), Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

KYONGBO PHARM.CO.,LTD. (2 trademarks)

174, Sirok-ro, Asan-si

Entity Type: 03

Trademark Details

Filing Date

September 3, 2025

Registration Date

Not Registered

Goods & Services

harmaceuticals for antibiotics, antifungal preparations, anti-viral agents, pharmaceutical preparations for treating diabetes, pharmaceutical preparations for treating hypertension, antihypertensives preparations, lipid lowering agents, antithrombotic preparation gastro-intestinal treatment preparations, analgesics, anti-inflammatory preparations, antiallergic medicines, pharmaceutical preparations for treating allergic rhinitis, asthma treatment preparations, pharmaceutical preparations for the treatment of rhinitis, preparations for the treatment of osteoporosis, pharmaceutical preparations acting on the central nervous system, pharmaceutical preparations for treating peripheral nervous system disorders, pharmaceutical preparations for the prevention of disorders of the nervous system, cardiovascular pharmaceutical preparations, anti-cancer preparations, local anesthetics preparations, sedatives preparations, dermatological pharmaceutical preparation, muscle relaxants preparations, hepatitis vaccine; pharmaceutical preparations for the treatment of the digestive system; pharmaceutical preparations for the treatment of central nervous system [CNS] diseases; pharmaceutical preparations for the treatment of the circulatory system; pharmaceutical preparations for the prevention of diseases of the respiratory system; pharmaceutical preparations for the treatment of disorders of the genitourinary system; pharmaceutical preparations for the treatment of osteoporosis; pharmaceutical preparations for the prevention of diabetes; pharmaceutical preparations for the treatment of allergies; pharmaceutical preparations for the treatment of Parkinson's disease; preparations for treatment of hepatitis; pharmaceutical for the treatment of erectile dysfunction; dietary supplement drinks; nutritional supplements; therapeutic drugs and agents in the nature of therapeutic pharmaceutical and agents for treating infectious diseases, skeletal and muscular disorders, cardiovascular and circulatory diseases, nervous system diseases, ocular disorders, respiratory diseases, gastrointestinal diseases, endocrine diseases, kidney diseases, hormonal diseases, and oncological diseases and disorders, pharmaceutical preparations for the treatment of musculoskeletal disorders, preparations for the treatment of hypercholesteremia; pharmaceutical agents affecting metabolism; vitamin and mineral supplements; medicinal healthcare preparations for supporting nutritional balance and overall well-being, namely, vitamin preparations, multivitamin preparations, nutritional supplements, dietary and nutritional supplements, protein dietary supplements, nutritional supplement energy bars, and powdered nutritional supplement drink mixes; nutraceutical preparations for use as a dietary supplement for therapeutic or medical purposes; nutraceuticals for use as a dietary supplement

Wholesale store services featuring pharmaceuticals; retail store services featuring pharmaceuticals; wholesale store services featuring pharmaceutical preparations for health care; retail store services featuring pharmaceutical preparations for health care; wholesale store services featuring dietary supplement drinks; retail store services featuring dietary supplement drinks; wholesale store services featuring nutritional supplements; retail store services featuring nutritional supplements; wholesale store services featuring nutraceuticals for use as a dietary supplement; retail store services featuring nutraceuticals for use as a dietary supplement; administrative processing of purchase orders; promoting the goods and services for others by means of operating an on-line comprehensive shopping mall with links to the retail websites for others; business intermediary services relating to mail order by telecommunications, namely, services featuring pharmaceutical products

Filing History

TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 14, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 14, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 14, 2026 TROA
REFUSAL PROCESSED BY IB
Mar 5, 2026 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Feb 14, 2026 RFCS
REFUSAL PROCESSED BY MPU
Feb 14, 2026 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jan 21, 2026 RFCR
NON-FINAL ACTION WRITTEN
Jan 20, 2026 CNRT
ASSIGNED TO EXAMINER
Jan 16, 2026 DOCK
APPLICATION FILING RECEIPT MAILED
Nov 21, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 21, 2025 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Nov 20, 2025 REPR